Collier, Jr.; Robert J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Collier, Jr.; Robert J..The latest application filed is for "use of monoamine oxidase inhibitors to treat outer retina disorders".

Company Profile

0.12.9

Collier, Jr.; Robert J. - Arlington TX US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of beta-adrenoceptor antagonists for the manufacture of a medicament of the treatment of disorders of the outer retina Grant 8,710,102 - Collier, Jr. , et al. April 29, 2	2014-04-29
Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen Grant 8,158,609 - Marsh , et al. April 17, 2	2012-04-17
Superoxide dismutase mimics for the treatment of ocular disorders and diseases Grant 8,067,405 - Klimko , et al. November 29, 2	2011-11-29
Superoxide dismutase mimics for the treatment of ocular disorders and diseases Grant 8,003,635 - Klimko , et al. August 23, 2	2011-08-23
Use of Monoamine Oxidase Inhibitors to Treat Outer Retina Disorders App 20110160308 - Collier, JR.; Robert J. ; et al.	2011-06-30
Use of Beta-Adrenoceptor Antagonists for the Manufacture of a Medicament for the Treatment of Disorders of the Outer Retina App 20100249134 - Collier, Jr.; Robert J. ; et al.	2010-09-30
Superoxide Dismutase Mimics For The Treatment Of Ocular Disorders And Diseases App 20100204194 - Klimko; Peter G. ; et al.	2010-08-12
Compounds with 5-HT.sub.1A activity useful for treating disorders of the outer retina Grant 7,763,619 - Collier, Jr. , et al. July 27, 2	2010-07-27
Superoxide dismutase mimics for the treatment of ocular disorders and diseases Grant 7,759,333 - Klimko , et al. July 20, 2	2010-07-20
Superoxide Dismutase Mimics For The Treatment Of Ocular Disorders And Diseases App 20100179117 - Klimko; Peter G. ; et al.	2010-07-15
Superoxide dismutase mimics for the treatment of ocular disorders and diseases Grant 7,754,706 - Klimko , et al. July 13, 2	2010-07-13
Compounds With 5-ht1a Activity Useful For Treating Disorders Of The Outer Retina App 20100168121 - Collier, JR.; Robert J. ; et al.	2010-07-01
Use Of Beta-adrenoceptor Antagonists For The Manufacture Of A Medicament For The Treatment Of Disorders Of The Outer Retina App 20080103211 - Collier, Jr.; Robert J. ; et al.	2008-05-01
Use of .beta.-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina Grant 7,081,482 - Collier, Jr. , et al. July 25, 2	2006-07-25
Superoxide dismutase mimics for the treatment of ocular disorders and diseases App 20050032768 - Klimko, Peter G. ; et al.	2005-02-10
Compounds with 5-ht activity useful for controlling visual field loss App 20030119846 - Collier Jr, Robert J. ; et al.	2003-06-26
Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina App 20020193373 - Collier, Jr., Robert J. ; et al.	2002-12-19
Angiostatic compounds Grant 5,719,167 - Doshi , et al. February 17, 1	1998-02-17
Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents Grant 5,646,149 - Hellberg , et al. July 8, 1	1997-07-08
Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents Grant 5,424,321 - Hellberg , et al. June 13, 1	1995-06-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.